Complement in Renal Disease as a Potential Contributor to Arterial Hypertension

Lisa-Maren Fischer1, Laura A Fichte1, Maike Büttner-Herold1

  • 1Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Insights

Renal complement deposition, including C1q and C3c, is linked to hypertension in rats and humans. Complement C3 is actively produced by kidney cells in hypertensive states, suggesting a role in hypertensive nephropathy.

Area of Science:

  • Nephrology
  • Immunology
  • Cardiovascular Research

Background:

  • Complement deposition is frequently observed in kidney biopsies of patients with arterial hypertension.
  • The direct association between hypertension and complement deposition, or complement's role in hypertensive nephropathy pathogenesis, remains unestablished.

Purpose of the Study:

  • To investigate the presence and significance of complement C1q and C3c deposition in a rat model of hypertension and in human renal biopsies from hypertensive patients.
  • To determine if complement components are actively expressed by renal cells in hypertensive conditions.

Main Methods:

  • Analyzed C1q and C3c deposition via immunohistochemistry in rat kidneys after subtotal nephrectomy (SNX) and in human renal biopsies (217 hypertensive, 91 controls).
  • Correlated complement deposition with renal function parameters and mean arterial blood pressure (BP) in rats.
  • Assessed C1q and C3 mRNA expression in rat and human kidney samples to evaluate active complement production.

Main Results:

  • Significantly higher glomerular C1q and C3c deposition in hypertensive SNX rats and hypertensive patients compared to controls.
  • Glomerular deposition correlated with mean arterial BP and left ventricular weight in hypertensive rats.
  • C3 mRNA expression confirmed active production by glomerular cells in hypertensive rats and humans; C3c staining intensity correlated with CKD stage in patients.

Conclusions:

  • Renal complement deposition is associated with experimental hypertension and hypertension in various renal diseases.
  • Further research is required to elucidate the causative role of renal complement in the pathogenesis of arterial hypertension in humans.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
274
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.9K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
966